Literature DB >> 20589462

Overt testicular disease at diagnosis in childhood acute lymphoblastic leukemia: prognostic significance and role of testicular irradiation.

R K Marwaha1, K P Kulkarni, D Bansal, A Trehan.   

Abstract

OBJECTIVE: To analyze the prognostic impact of overt testicular disease (OTD) at diagnosis and role of testicular irradiation in the same.
METHODS: Data of 579 boys treated at our center over 16 years was reviewed.
RESULTS: Fourteen (2.4%) males had OTD. 10 (71.4%) of these had high-risk disease. Patients with OTD, had a significantly higher incidence of mediastinal-adenopathy (p=0.001), hyperleucocytosis (p=0.004) and CNS disease at presentation (p<0.0001) compared to patients in continuous complete remission (CCR). 4 of the 11 patients with OTD, who opted for therapy, had relapse; 2 are in CCR. Although, survival in patients with OTD was inferior (p=0.183) compared to patients without OTD, it was not an independent prognostic factor (p=0.47). In the entire study cohort, symptom-diagnosis interval (p=0.006), white cell (p=0.001) and platelet count (p=0.001) at presentation were significantly associated with survival (Cox multivariate regression analysis).
CONCLUSIONS: OTD was not an independent prognostic factor, despite association with high-risk features. Survival outcome was inferior. The observations indicate the need of revaluation of the present protocol with incorporation of intermediate dose and subsequently high-dose methotrexate (after assessment for toxicity and tolerance), risk-stratified therapy and plausibly omission of testicular irradiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20589462     DOI: 10.1007/s12098-010-0119-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  20 in total

1.  MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.

Authors:  J M Chessells; C C Bailey; S Richards
Journal:  Leukemia       Date:  1992       Impact factor: 11.528

2.  Survival of childhood acute lymphoblastic leukemia: results of therapy at Tata Memorial Hospital, Bombay, India.

Authors:  S J Vaidya; S H Advani; S K Pai; C N Nair; P A Kurkure; T K Saikia; R Gopal; V R Pai; K S Nadkarni; P M Parikh
Journal:  Leuk Lymphoma       Date:  1996-01

3.  Four-agent induction/consolidation therapy for childhood acute lymphoblastic leukemia: an Indian experience.

Authors:  S H Advani; R S Iyer; S K Pai; R Gopal; T K Saikia; C N Nair; P A Kurkure; K S Nadkarni; V R Pai
Journal:  Am J Hematol       Date:  1992-04       Impact factor: 10.047

4.  Overt testicular disease at diagnosis of childhood acute lymphoblastic leukemia: lack of therapeutic role of local irradiation.

Authors:  N Hijiya; W Liu; J T Sandlund; S Jeha; B I Razzouk; R C Ribeiro; J E Rubnitz; S C Howard; E P Kyzer; D S Redd; C Cheng; G K Rivera; M M Hudson; M V Relling; C-H Pui
Journal:  Leukemia       Date:  2005-08       Impact factor: 11.528

5.  Overt testicular disease (OTD) at diagnosis is not associated with a poor prognosis in childhood acute lymphoblastic leukemia: results of the EORTC CLG Study 58881.

Authors:  Nicolas Sirvent; Stefan Suciu; Yves Bertrand; Anne Uyttebroeck; Brigitte Lescoeur; Jacques Otten
Journal:  Pediatr Blood Cancer       Date:  2007-09       Impact factor: 3.167

6.  Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lymphoblastic leukemia.

Authors:  A Gajjar; R C Ribeiro; H H Mahmoud; J T Sandlund; Q Liu; W L Furman; V M Santana; W M Crist; G K Rivera; C H Pui
Journal:  Cancer       Date:  1996-12-01       Impact factor: 6.860

7.  Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse.

Authors:  M L Brecher; V Weinberg; J M Boyett; L F Sinks; B Jones; A Glicksman; J F Holland; A I Freeman
Journal:  Cancer       Date:  1986-09-01       Impact factor: 6.860

8.  Survival outcome in childhood ALL: experience from a tertiary care centre in North India.

Authors:  K P Kulkarni; R K Marwaha; A Trehan; D Bansal
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

9.  Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.

Authors:  C H Pui; H H Mahmoud; G K Rivera; M L Hancock; J T Sandlund; F G Behm; D R Head; M V Relling; R C Ribeiro; J E Rubnitz; L E Kun; W E Evans
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

10.  Prognostic variables and survival in pediatric acute lymphoblastic leukemias: cancer institute experience.

Authors:  V Shanta; V Maitreyan; T G Sagar; C K Gajalakshmi; K R Rajalekshmy
Journal:  Pediatr Hematol Oncol       Date:  1996 May-Jun       Impact factor: 1.969

View more
  1 in total

1.  Cytopathological Diagnosis of an Unusual Cause of Malignant Hydrocele.

Authors:  Ankur Jain; Alka Khadwal; Gaurav Prakash; Nalini Gupta; Subhash Varma; Pankaj Malhotra
Journal:  Clin Med Insights Pathol       Date:  2016-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.